38742194|t|Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy.
38742194|a|Increasing evidence suggests that female individuals have a higher Alzheimer's disease (AD) risk associated with post-menopausal loss of circulating estradiol (E2). However, clinical data are conflicting on whether E2 lowers AD risk. One potential contributing factor is APOE. The greatest genetic risk factor for AD is APOE4, a factor that is pronounced in female individuals post-menopause. Clinical data suggests that APOE impacts the response of AD patients to E2 replacement therapy. However, whether APOE4 prevents, is neutral, or promotes any positive effects of E2 is unclear. Therefore, our goal was to determine whether APOE modulates the impact of E2 on behavior and AD pathology in vivo. To that end, mice that express human APOE3 (E3FAD) or APOE4 (E4FAD) and overproduce Abeta42 were ovariectomized at either 4 months (early) or 8 months (late) and treated with vehicle or E2 for 4 months. In E3FAD mice, we found that E2 mitigated the detrimental effect of ovariectomy on memory, with no effect on Abeta in the early paradigm and only improved learning in the late paradigm. Although E2 lowered Abeta in E4FAD mice in the early paradigm, there was no impact on learning or memory, possibly due to higher Abeta pathology compared to E3FAD mice. In the late paradigm, there was no effect on learning/memory and Abeta pathology in E4FAD mice. Collectively, these data support the idea that, in the presence of Abeta pathology, APOE impacts the response to E2 supplementation post-menopause.
38742194	0	9	Estradiol	Chemical	MESH:D004958
38742194	31	34	FAD	Disease	MESH:D000544
38742194	46	50	mice	Species	10090
38742194	64	69	APOE3	Gene	348
38742194	78	83	APOE4	Gene	348
38742194	170	189	Alzheimer's disease	Disease	MESH:D000544
38742194	191	193	AD	Disease	MESH:D000544
38742194	252	261	estradiol	Chemical	MESH:D004958
38742194	263	265	E2	Chemical	MESH:D004958
38742194	318	320	E2	Chemical	MESH:D004958
38742194	328	330	AD	Disease	MESH:D000544
38742194	374	378	APOE	Gene	348
38742194	417	419	AD	Disease	MESH:D000544
38742194	423	428	APOE4	Gene	348
38742194	524	528	APOE	Gene	348
38742194	553	555	AD	Disease	MESH:D000544
38742194	556	564	patients	Species	9606
38742194	568	570	E2	Chemical	MESH:D004958
38742194	609	614	APOE4	Gene	348
38742194	673	675	E2	Chemical	MESH:D004958
38742194	733	737	APOE	Gene	348
38742194	762	764	E2	Chemical	MESH:D004958
38742194	781	783	AD	Disease	MESH:D000544
38742194	816	820	mice	Species	10090
38742194	834	839	human	Species	9606
38742194	840	845	APOE3	Gene	348
38742194	847	852	E3FAD	Disease	
38742194	857	862	APOE4	Gene	348
38742194	864	869	E4FAD	Disease	
38742194	989	991	E2	Chemical	MESH:D004958
38742194	1009	1014	E3FAD	Disease	
38742194	1015	1019	mice	Species	10090
38742194	1035	1037	E2	Chemical	MESH:D004958
38742194	1115	1120	Abeta	Gene	11820
38742194	1201	1203	E2	Chemical	MESH:D004958
38742194	1212	1217	Abeta	Gene	11820
38742194	1221	1226	E4FAD	Disease	
38742194	1227	1231	mice	Species	10090
38742194	1321	1326	Abeta	Gene	11820
38742194	1349	1354	E3FAD	Disease	
38742194	1355	1359	mice	Species	10090
38742194	1426	1431	Abeta	Gene	11820
38742194	1445	1450	E4FAD	Disease	
38742194	1451	1455	mice	Species	10090
38742194	1524	1529	Abeta	Gene	11820
38742194	1541	1545	APOE	Gene	348
38742194	1570	1572	E2	Chemical	MESH:D004958
38742194	Negative_Correlation	MESH:D004958	11820
38742194	Association	MESH:D000544	348
38742194	Negative_Correlation	MESH:D004958	MESH:D000544

